All malaria-endemic countries in Africa are on a sliding scale towards a malaria-free future. Bold and ambitious goals around malaria elimination were adopted by the United Nations General Assembly in September 2015 through target 3.3 of the Sustainable Development Goals; by Africa’s leaders through the Africa Agenda 2063; and by the World Health Assembly in May 2015 through the Global Technical Strategy for Malaria 2016–2030, known as the GTS. The GTS has four 2030 goals and targets: reduce malaria mortality rates globally by at least 90% compared with 2015; reduce malaria case incidence globally by at least 90% compared with 2015; eliminate malaria from at least 35 countries in which malaria was transmitted in 2015; and prevent re-establishment of malaria in all countries that are malaria-free. The post-2015 period therefore presents a scenario of bold reforms intended to actualize a malaria-free future. In order to align the GTS to the African context, the Framework for implementing the Global Technical Strategy for Malaria 2016–2030 in the African Region was developed.
Working the night shift on Malaria's frontline in Sierra Leone
It's night-time at Ola During Children's Hospital in Freetown, Sierra Leone and doctors Nehlama Barrie and Winstina Gbondo are on shift. Most nights here see children die of Malaria complications but a free health programme has given them a fighting chance of saving lives.
Filmmakers: Paul Myles and Zoe Jewell
Producer: Abdul Samba Brima
Editor: Brad Hayward
27 May 2019
Watch this video
Algeria and Argentina certified ‘malaria-free’ by WHO, journalists from high burden countries begin RBM media fellowship and Dr Pedro Alonso speaks at the World Health Assembly.
Listen to this Podcast
World Health Organization, Geneva, 22 May 2019
Algeria and Argentina have been officially recognized by WHO as malaria-free. The certification is granted when a country proves that it has interrupted indigenous transmission of the disease for at least 3 consecutive years.
The 5th International conference on Malaria Vaccines for the World (MVW) was held on May 8-10 at the University of Oxford, UK. The current status of new technologies, vaccine candidates, clinical trials and the RTS/s implementation studies were discussed during three intensive days, and here you can read coverage of each session from the MESA Correspondents.
- Poor quality anti-malarial drugs causing resistance to develop
- Quality control of drugs essential at all stages before administration
- Health professionals must be trained to detect substandard drugs
Ministerial meeting regarding malaria is arranged for the World Health Assembly, the ‘Malaria Vaccines for the World’ event takes place in Oxford and submissions open for the ‘Malaria in Melbourne’ conference.
Listen to this Podcast
Malaria Minute, 10 May 2019
Rory Stewart becomes new Secretary of State for International Development, PMI release their thirteenth Annual Report and the MalaFA report shares the opinion of African experts.
Listen to this podcast
We are a group of four MSc students from the TU Delft in the Netherlands and working on a new mosquito bait to kill mosquitos and reduce the spreading- and infection of malaria. In order to further develop the prorotypes, test them in Kenya and ensure successful implementation, we set up a crowdfunding campaign.
MalaFA (Malaria Futures for Africa) is an opinion research study. It is the first systematic effort in many years to collect expert African views on malaria policy. It was commissioned by Novartis Social Business to capture the thoughts of 68 African malaria experts in 14 sub-Saharan African countries – ministers of health, members of parliament, senior civil servants working in health, heads of national malaria control programmes and representatives of academia and non-governmental organisations (NGOs) working on malaria.
The Compendium of WHO malaria guidance provides, for the first time, a complete list of all formal WHO policy recommendations on malaria in a single resource. The document also serves as a catalogue of all WHO publications on malaria prevention, diagnosis, treatment, surveillance and elimination.
Paris, 25 April 2019 – Today leaders from across the globe meet in Paris to renew commitments and announce new initiatives to accelerate the global movement to end malaria in our lifetime.
“For World Malaria Day, we’re joining countries and partners with a clear message: ‘Zero malaria starts with me,’” says the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, in his World Malaria Day message. “We’re calling on political leaders, the private sector and affected communities to take action to improve prevention, diagnosis and treatment of malaria. We all have a role to play.”
IN 30 SECONDS: There is no doubt that bed nets, insecticides, medicines and diagnostics will deliver significant successes against malaria in the short-term. But as major international partners continue prioritizing the commodity-based approach, African governments should be building the necessary resilience in affected communities. Countries should ensure safe houses and physical environments so that exposure to mosquito bites is minimized, strengthen health systems to identify and treat new malaria cases, expand access to health education in schools and households, and improve household economies and food security so that competing priorities are addressed. This needs to be a long-term strategy, paid for by domestic funding, subsidies, tax rebates or other innovative financing mechanisms – for example a ten-dollar malaria levy paid by international travelers visiting endemic countries. This way, the affected countries can better avoid malaria deaths and sickness, or rebounds of transmission, which currently place such a strain on national health outcomes and development.
Country first of three in Africa to roll out landmark vaccine
WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine today in a landmark pilot programme. The country is the first of three in Africa in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age; Ghana and Kenya will introduce the vaccine in the coming weeks.
Nature News, 16 April 2019
A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions.
Keeping you up to date with the latest malaria news
Fight Malaria uses the power of podcasting to connect the dots between the global efforts to eradicate malaria. The Malaria Minute podcastbrings global malaria news to you in 60 seconds. The Five Minutes podcast highlight people fighting malaria on the forefront.
If you are working on malaria in East or Southern Africa you are invited to participate in the survey of the Embassy of Switzerland to Tanzania and Zambia.*
Cyclone Idai Causes ‘Spike’ in Malaria Cases
By Thomas Locke
Cyclone Idai causes ‘spike’ in malaria cases, Oxford Uni researchers head to Africa to sequence mosquito DNA and the NothingButNets Leader Summit takes place in the US capitol.
Listen to this podcast
The University of Malaya hosted the "Current Tools to Combat Malaria - with Special Focus on Plasmodium knowlesi" workshop on March 4 - 8, 2019, which had 20 participants from eight different countries. Dr Lucas Low Van Lun covered this intensive week of lectures and practical sessions and reported the daily lessons learnt in a series of reports posted in the Resource Hub.
The Guidelines for malaria vector control provide a “one-stop shop” for all countries and partners working to implement effective malaria vector control measures. They cover the 2 core malaria vector control interventions – ITNs and IRS – as well as supplementary interventions, namely chemical and biological larvicides, and personal protection measures, such as the use of topical repellents.
Geneva – Paris, 25 February 2019 Today the RBM Partnership to End Malaria announced that Paris, France, will be the official host city of World Malaria Day 2019 on 25th April.
This report has been prepared to provide a comprehensive account of the history of malaria and its control in the Islamic Republic of Iran for specialists and lay readers alike. It is based on published and unpublished reports, especially from the Ministry of Health and Medical Education, Tehran, and from the World Health Organization. The main findings are summarized below.
Attention is drawn to the following three publications that are relevant to the preparation of manuscripts on malaria:
Markus, M.B. 2019. Plasmodium – Yet More Don’ts. Trends in Parasitology 35 (2): 101–102.
McFadden, G.I. 2019. Plasmodium – More Don’ts. Trends in Parasitology 35 (1): 4–6.
An article on vivax malarial recurrences was highlighted in the "Global Malaria News" section of last week's MalariaWorld Newsletter. Below (in the next paragraph) is a relevant explanation concerning the article (http://theconversation.com/why-does-malaria-recur-how-pieces-of-the-puzz...):
WHO is undertaking a consultative process to solicit inputs into a prioritization framework for the research and development (R&D) of malaria health products. A draft report “Analysis of Malaria R&D Priorities” identifies five key challenges that represent threats or barriers to achieving the WHO Global Technical Strategy for Malaria 2016–2030 goals. This early copy of the report is being shared at a time when WHO is exploring how best to guide and support the development of priority solutions to meet public health needs.
WHO welcomes feedback on this draft report until 28 February 2019, including the correction of errors or omissions, updates to product development pipelines, and perspectives on the approach to prioritization.